Clinical-stage company OncoMed Pharmaceuticals has announced the issuance of US patent for methods of treating cancer with its antibody vantictumab (OMP-18R5) through 2029. Targeting and inhibiting the Wnt pathway, Vantictumab was ...
Tags: Vantictumab, OncoMed
Celgene International's oral anti-cancer therapy Pomalidomide has won European Commission approval as treatment for patients with relapsed/refractory multiple myeloma (rrMM), a rare form of blood cancer, in combination with dexamethasone. ...
Tags: Anti-Cancer Therapy
Regen BioPharma, a wholly owned subsidiary of Bio-Matrix Scientific, has signed a licensing deal with Benitec Biopharma for ddRNAi gene silencing technology to develop vaccines. Regen will apply ddRNAi to silence indoleamine 2,3 -- ...
Tags: Regen BioPharma, Medicine
The Intellectual Property Appellate Board (IPAB) in India has cancelled the patent for GlaxoSmithKline's (GSK) anti-cancer drug Tykerb in its salt form over failure in demonstrating significant improvement in the efficacy. Fresenius ...
Tags: Anti-Cancer Drug
Clinical stage biopharma company Rexahn Pharmaceuticals has entered into an exclusive licensing agreement with the University of Maryland, Baltimore (UMB), for a novel drug delivery platform, which targets the delivery of chemotherapeutic ...
Tags: Rexahn Pharma, Oncology Drug
The US Patent and Trademark Office (USPTO) has granted a patent to GenSpera for the activation of peptide prodrugs by HK2, which is an enzyme secreted by prostate cancer cells. Composition of a series of prodrugs activated by HK2 enzyme ...
Tags: Peptide Prodrugs, Medicine
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Celgene International's oral anti-cancer therapy Pomalidomide. The positive results from the MM-003 study of ...
Oncology-focused company Curis has announced the approval of Erivedge (vismodegib) in Australia for the treatment of metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma in adult patients who are not suitable for ...
Tags: Curis, Erivedge Anti-Cancer Drug
The Indian Supreme Court has rejected Novartis' patent application for its anti-cancer drug Glivec (imatinib mesylate) saying that “application for patent on the beta-crystalline salt does not meet any standard of novelty or ...
Tags: Indian Apex, Novartis'Patent Plea, Glivec
The European Commission (EC) has granted conditional marketing authorization for Pfizer's Bosulif (bosutinib) anti-cancer drug in the European Union (EU). Bosulif is authorized in Europe for the treatment of adult patients with chronic ...
Tags: Pfizer Bosulif, cancer drug, drug
Ablynx has signed a collaborative agreement with Spirogen to evaluate the potential of a novel anti-cancer drug conjugate. As part of the deal, both the firms will evaluate anti-cancer drug conjugate by using Spirogen's proprietary ...
Tags: Ablynx inks, anti cancer drug, drug
On Feb. 13-14, 2013, the healthcare industry's major players will convene at the 12th edition of Pharmapack Europe at Grande Halle de la Villette (Paris). More than 3,000 visitors from four continents and more than 290 international ...
Tags: Pharmaceutical Packaging, Packaging Experts, Key Issues
US-based Blend Therapeutics has appointed Mark Iwicki as its president, chief executive officer and a member of the board of directors. Iwicki comes with more than 23 years of experience in the pharmaceutical industry with experience in ...
Tags: Blend Therapeutics, CEO, Iwicki, drug development
Two U.S. agencies have seized 686 websites accused of selling counterfeit and illegal medicines as part of an international crackdown on online sales of fake drugs. U.S. Immigration and Customs Enforcement's (ICE) Homeland Security ...
Tags: U.S.agencies, websites, counterfeit and illegal medicines, online sales
OncoSec Medical has obtained CE certification for its proprietary gene and drug delivery technology, designed to treat solid tumor cancers. The assessment and certification process was supervised by SGS Group, a provider of inspection, ...
Tags: OncoSec, CE certification, proprietary gene, drug delivery technology